Skip to main content
  • Policy
    Get Involved
    Watch Best of BIO
    Advocacy Toolkit
    BIOAction
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    Agriculture & Environment
    Food and Farm Innovation
    Sustainable Fuels
    Biobased Manufacturing
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Join Today
    Member Directory
    Have a Voice
    Membership Eligibility
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member ag&evnt
    Agriculture & Environment
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    BIO Business Solutions
    Join Today
  • News & Insights
    Latest blogs on BIOtechNOW
    Watch Best of BIO
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    Good Day BIO
    I AM BIO Podcast
    All News & Insights

    Sign up for the Good Day BIO Newsletter >

  • BIOEquality
    1. Promote

    Health equality in access to medicines and ensuring diversity in clinical trials.

    2. Invest

    In the current and next generation of black scientists and entrepreneurs.

    3. Expand

    Opportunities for women, Black and other minority populations in the growing Bio-economy.

    The Right Mix Matters

    Providing tools to accelerate gender, racial, ethnic and LGBTQ representation on biotech company boards, in C-suites and in functional leadership positions.

  • Events
    Event Portfolio
    Business Development
    Health
    Agriculture & Environment
    International
    Members Only
    All Events
    BIO Digital 2021

    June 10-11 & 14-17

    New extended dates for the world’s largest biotech partnering event

    Subscribe for Updates
    BIO Partnering @ JPM
    BIO Partnering @ JPM

    January 11-15, 2021
    Fostering the Success of the Industry

    Evt Bif MegaMenu
    BIO Investor Forum Digital

    October 19-20, 2021
    Watch the Best of BIO Sessions

    Evt CEO MegaMenu
    BIO CEO & Investor Digital Conference

    Feb 16-18, 2021
    Accelerate Discovery. Amplify Returns.

    BIO Online Learning

    BIO now offers on-demand online classes that can be taken anywhere, anytime and at your own pace. BIO Member and group discounts available!

  • About
    About Us
    Learn about our mission, vision, values and priorities
    Programs & Initiatives
    Find out about BIO's programs & initiatives
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • How Do I
    How Do I?

    Connect with BIO to save money, meet partners and expand your influence by promoting your company and joining our advocacy efforts. Join to get started today!

    Shape Policy
    Save Money
    Meet Partners
    Promote
    Get Started
    Join Today
  • Search
Logo
Logo
Home
Search
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
Logo
Logo
Search
Explore the Blog
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
444 Results Found

BIO CEO 2020
Election Outlook: Explaining Healthcare Policy Proposals’ Impacts on Innovation and Patients
“The promise for patients has never been better from a scientific point of view,” said BIO CEO and former Member of Congress Jim Greenwood, speaking at the 22nd BIO CEO & Investor Conference in New York. “But it’s the worst of times politically.” Specifically: There are “mountains of political…

BIO CEO & Investor Conference
Expanding the Toolkit for Fighting Solid Tumors
As the biotech industry advances scientific discovery around new tumor types and mechanisms of action, we’ve seen more than 2,000 combination trials launched to enhance PD-1/L1 checkpoint inhibitors’ effects on solid tumors. The oncology pipeline has some exciting new biotechnological approaches…

Coronavirus
Biopharma Experts Discuss Response Efforts to Coronavirus Outbreak
At the time this blog was published, the coronavirus had taken more than 500 lives across the globe and infected more than 28,000 people across 25 countries. While these numbers are alarming, hope is on the horizon – and America’s biopharmaceutical industry is leading the charge.  In a…

2009-2018 venture-investment-into-US-Companies-with-lead-novel-drug
The State of Investment and Innovation in Hypertension and Heart Failure
BIO’s Industry Analysis team has published its 5th report in a series on the innovation landscape of highly prevalent, chronic diseases. This new report [available here] reviews the state of drug development for hypertension and heart failure. As with the prior reports, the investigation into these…

Stopping Outbreaks Through One Health
Stopping Outbreaks Through One Health: Making Tomorrow's Breakthroughs Possible
The rapid spread of the coronavirus out of Wuhan, China has sparked concern across countries as the international community grapples with how best to contain it. The clock is ticking to find a solution. Luckily, innovative biotechnology companies are working tirelessly each today to heal the world…

BTN Blog Top Card Health
Is ICER Changing the Rules to Reach It’s Desired Outcome?
Jennifer Bright with the Innovation and Value Initiative recently wrote for Morning Consult that the U.S. is “engaged in the challenging but important conversation about how to assess the value of pharmaceuticals.”  It’s a conversation that should be transparent and open to everyone,…

BTN Blog Top Card Health
GAO Report Exposes New Weaknesses in 340B Drug Discount Program
The 340B Drug Discount Program is in the spotlight with the release of a new report from the Government Accountability Office (GAO) calling attention to oversight of the program designed to help vulnerable patients gain access to affordable prescription drugs. As the findings show, the program,…

Veterans Are Under
Veterans Are Under-Represented in Clinical Studies. NAVREF Is Working to Change That.
Rick Starrs, CEO of NAVREF When it comes to clinical research trials, America leads the world in providing patients with access to the latest, state-of-the-art care. However, an under-represented population in clinical studies might surprise you: veterans. To correct this shortfall,…

USMCA
3 Key Points on Biologics & USMCA
This week, Congress is expected to consider a USMCA trade agreement that does NOT include stronger IP protections for American innovators who develop biologic medicines. While the removal of these provisions is being hailed as a defeat for Big Pharma, here are three key points to keep in mind as…

The Door is Open to Tackling Cancer in Africa
Calling Industry: The Door is Open to Tackling Cancer in Africa
By 2040, experts say the number of yearly cancer cases in Africa will double. In 2018 alone, cancer deaths in Africa (over 530,000) were 30 percent higher than deaths from malaria. Clearly, a shift in disease burdens has taken place on the continent. Biotechnology and pharmaceutical companies are…

Pagination

  • « « First
  • ‹ ‹‹
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • › ››
  • » Last »
Explore BIO
Policy
Events
Industry Insights
About
Join Now
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Digital
BIO CEO & Investor Conference
BIO Investor Forum Digital
BIO IMPACT Digital
BIO Online Learning
BIO DOUBLE HELIX SPONSORS
Eli Lilly and Company
Amgen
Bristol Myers Squibb
Genentech Logo
Johnson & Johnson Logo
Merck
MSD
BIO HELIX SPONSORS
Pfizer Inc logo
Sanofi Logo
AbbVie Logo
1201 Maryland Avenue SW, Suite 900, Washington, DC, 20024 ・ 202-962-9200
© BIO 2021 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO